{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:54:34Z","timestamp":1791356074251,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.ijpharm.2004.01.016","type":"journal-article","created":{"date-parts":[[2004,2,27]],"date-time":"2004-02-27T05:21:49Z","timestamp":1077859309000},"page":"185-190","source":"Crossref","is-referenced-by-count":43,"title":["Iontophoresis of lecithin vesicles of cyclosporin A"],"prefix":"10.1016","volume":"274","author":[{"given":"Ramesh R","family":"Boinpally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopinath","family":"Devraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratap K","family":"Anne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasu","family":"Poondru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskara R","family":"Jasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2004.01.016_BIB1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF01962250","article-title":"Cyclosporin A: correlation between HPLC and RIA serum levels","volume":"4","author":"Abisch","year":"1982","journal-title":"Pharm. Weekbl. Sci."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB2","first-page":"582","article-title":"Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical and immunohistochemical investigation","volume":"66","author":"Aldridge","year":"1986","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/BF02154739","article-title":"The effect of topical cyclosporin A on the rabbit cornea. A clinical and electron microscopic study","volume":"224","author":"Behrens-Baumann","year":"1986","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB4","first-page":"660","article-title":"Transdermal application of cyclosporine prolongs skin allograft survival","volume":"20","author":"Black","year":"1988","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/1523-1747.ep12876218","article-title":"Site-specific suppression of cell-mediated immunity by cyclosporine","volume":"94","author":"Black","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB6","first-page":"120","article-title":"Mechanisms of site-specific immunosuppression","volume":"23","author":"Black","year":"1991","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB7","unstructured":"Boinpally, R.R., Zhou S., Poondru, S., Jasti, B.R., 2001. Transdermal delivery of insulin using lecithin vesicles AAPS. Pharm. Sci. 3 (S1)."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0005-2736(97)00177-6","article-title":"Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin","volume":"1368","author":"Cevc","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0536.1988.tb05510.x","article-title":"The effect of topical cyclosporin A on the elicitation phase of allergic contact dermatitis","volume":"19","author":"Cole","year":"1988","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(86)90315-6","article-title":"Placebo-controlled trial of topical cyclosporin in severe alopecia areata","volume":"2","author":"de Prost","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2133.1990.tb01480.x","article-title":"Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activity","volume":"123","author":"Duncan","year":"1990","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-5173(01)00627-5","article-title":"Effect of liposomes and niosomes on skin permeation of enoxacin","volume":"219","author":"Fang","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bjo.69.8.600","article-title":"Prolonged survival of allogeneic corneal grafts in rabbits treated with topically applied cyclosporin A: systemic absorption and local immunosuppressive effect","volume":"69","author":"Foets","year":"1985","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0378-5173(99)00361-0","article-title":"Lecithin vesicular carriers for transdermal delivery of cyclosporin A","volume":"194","author":"Guo","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000210782","article-title":"Topical ciclosporin for psoriasis: in vitro skin penetration and clinical study","volume":"1","author":"Hermann","year":"1988","journal-title":"Skin Pharmacol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB17","first-page":"922","article-title":"Overview of a 10-year experience on methods and compositions for inducing site-specific immunosuppression with topical immunosuppressants","volume":"28","author":"Hewitt","year":"1996","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB18","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00007890-199505270-00022","article-title":"Site-specific immune suppression with topical cyclosporine. Synergism with combined topical corticosteroid added during the maintenance phase","volume":"59","author":"Llull","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.2042-7158.1996.tb03910.x","article-title":"Evaluation of in-vivo transdermal absorption of cyclosporin with absorption enhancer using intradermal microdialysis in rats","volume":"48","author":"Nakashima","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archderm.123.2.165","article-title":"Topical cyclosporine in alopecia areata","volume":"123","author":"Parodi","year":"1987","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB21","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1002\/eji.1830251248","article-title":"Transdermal immunization with large proteins by means of ultradeformable drug carriers","volume":"25","author":"Paul","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0264-410X(97)00185-0","article-title":"Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes","volume":"16","author":"Paul","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0169-409X(00)00138-1","article-title":"The role of electroosmotic flow in transdermal iontophoresis","volume":"46","author":"Pikal","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB24","first-page":"344","article-title":"Digital image analysis of major histocompatibility complex class I and class II expression during site-specific immune suppression with topical cyclosporine","volume":"27","author":"Tatem","year":"1995","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01972366","article-title":"Cyclosporine: immunology, toxicity and pharmacology in experimental animals","volume":"15","author":"Thomson","year":"1984","journal-title":"Agents Actions"},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/jsre.1999.5582","article-title":"Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate\/caprate","volume":"83","author":"Tran","year":"1999","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-3659(97)00117-X","article-title":"Transdermal delivery of cyclosporin-A using electroporation","volume":"50","author":"Wang","year":"1998","journal-title":"J. Control Release"},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB28","first-page":"437","article-title":"Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeks","volume":"64","author":"Whiting","year":"1983","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.ijpharm.2004.01.016_BIB29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bjo.71.3.239","article-title":"Topical steroid, cyclosporin A, and the outcome of rat corneal allografts","volume":"71","author":"Williams","year":"1987","journal-title":"Br. J. Ophthalmol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T18:23:27Z","timestamp":1550168607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517304000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0378517304000328"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2004.01.016","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}